Dr. Fiona Gilbert from the University of Cambridge discusses the grave threat that the U.K.'s Brexit poses to the future of imaging research, and she also speaks about the persistent controversies in breast cancer screening and the growing potential of digital breast tomosynthesis.
Pre-Info from Phillip Ward (this info is not for unchecked publishing): Breast cancer screening with tomosynthesis: the time is now Prof. Fiona J. Gilbert, Cambridge, U.K.Video from ECR 2017: Dr. Fiona Gilbert on Brexit & breast screening
Mar 1, 2017
Latest in Conference
Guerbet to celebrate 100-year anniversary at ECR 2026
February 18, 2026
Fujifilm to collaborate with Amazon at ECR 2026
February 13, 2026
AGFA HealthCare to highlight platform advances at ECR 2026
January 29, 2026
Bayer to emphasize phase III clinical trial data at ECR 2026
January 29, 2026



















